Clinical Applicability of Whole-Exome Sequencing Exemplified by a Study in Young Adults with the Advanced Cryptogenic Cholestatic Liver Diseases

<div>Distribution of ratios between observed and expected number of rare variants, measured for variants with EUR MAF lesser than 0.01, 0.02, 0.05, and 0.1 measured between available fathers in sequenced families.</div>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: Clinical Applicability of Whole-Exome Sequencing Exemplified by a Study in Young Adults with the Advanced Cryptogenic Cholestatic Liver Diseases 

Figure 1 | Clinical Applicability of Whole-Exome Sequencing Exemplified by a Study in Young Adults with the Advanced Cryptogenic Cholestatic Liver Diseases 